Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Qinliang Fang"'
Autor:
Changhong Luo, Yuyan Lu, Qinliang Fang, Jing Lu, Ping Zhan, Wenqing Xi, Jinzhu Wang, Xijun Chen, Qin Yao, Fuqiang Wang, Zhenyu Yin, Chengrong Xie
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-15 (2024)
Abstract Hepatocellular carcinoma (HCC) is a prevalent malignant tumor worldwide. Tripartite motif containing 55 (TRIM55), also known as muscle-specific ring finger 2 (Murf2), belongs to the TRIM protein family and serves as an E3 ligase. Recently, t
Externí odkaz:
https://doaj.org/article/0bd9e1997a844a6b90b30965474553d2
Publikováno v:
Cellular Physiology and Biochemistry, Vol 40, Iss 1-2, Pp 287-296 (2016)
Background: Recent studies reveal that long non-coding RNAs (LncRNAs) play critical roles in the proliferation and migration of human cancer. Previous report has shown that LncRNA HOXA-AS2 was involved in carcinoma processes. However, the expression
Externí odkaz:
https://doaj.org/article/4f45715771214aa5a2d20ed6c1b8b9f6
Autor:
Qinliang Fang, Fuqiang Wang, Chengrong Xie, Jie Lv, Fei Wang, Sheng Zhang, Yaping Xu, Zhenyu Yin, Sen Zheng, Jing Lu, Qing Bao, Huita Wu, Yuyan Lu
Publikováno v:
Cancer Management and Research. 11:4529-4540
Background: Due to the high recurrence and metastasis rate, the clinical outcomes of patients with hepatocellular carcinoma (HCC) are still unsatisfactory. Hepatitis B virus X-interacting protein (HBXIP) has been reported to play crucial roles in car
Autor:
Ping Zhan, Xiuming Zhang, Fuqiang Wang, Qinliang Fang, Sheng Zhang, Chengrong Xie, Huita Wu, Yuyan Lu, Fei Wang, Zhenyu Yin, Jing Lu
Publikováno v:
Cancer Management and Research. 11:2485-2497
Background: Hepatocellular carcinoma (HCC) is one of the most frequent cancers and the third leading cause of cancer-related deaths. It has been reported that lysosomal associated transmembrane protein LAPTM4B expression is significantly upregulated
Autor:
Dongliang Zuo, Hongzhi Liu, Dongxu Liu, Qinliang Fang, Pengtao Li, Liang Tu, Yu Xiong, Yongyi Zeng, Pingguo Liu
Publikováno v:
Journal of Clinical and Translational Hepatology. :000-000
Autor:
Jian-Yin Zhou, Zhenyu Yin, Guo-Hui Luo, Qinliang Fang, Fuqiang Wang, Chengrong Xie, Yu Xiong, Yun-Tong Li
Publikováno v:
Bioscience Reports
A newly identified lncRNA designated as RP11-284P20.2 has been identified to be up-regulated in hepatocellular carcinoma (HCC), but its role in HCC remain poorly understood. Quantitative PCR and immunocytochemical analysis were performed using the HC
Autor:
Qinliang Fang, Zhao Li, He-Qiang Qi, Fuqiang Wang, Sen Zheng, Chengrong Xie, Jie Lv, Sheng Zhang, Xiaomin Wang, Zhenyu Yin, Fei Wang
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 9, Iss C, Pp 440-451 (2017)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Long noncoding RNAs (lncRNAs) are a new class of regulatory noncoding RNAs. Emerging evidences indicate that lncRNAs play a critical role in the development of hepatocellular carcinoma (HCC). Although several lncRNAs have been annotated, the associat
Autor:
Huita Wu, Jing Lu, Qinliang Fang, Ping Zhan, Wenxiu Zhao, Sheng Zhang, Jie Lv, Yuyan Lu, Zhenyu Yin, Chengrong Xie, Junjiang Lu, Fuqiang Wang
Publikováno v:
Cancer letters. 469
Hepatocellular carcinoma (HCC) has emerged as one of the most common malignancies worldwide. It is associated with a high mortality rate, as evident from its increasing incidence and extremely poor prognosis. The deubiquitinating enzyme 26S proteasom
Publikováno v:
Bioscience Reports
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. Recently, ubiquitin-conjugating enzyme E2C (UBE2C) has been reported to be overexpressed in human cancers and act as a potential oncogene. However, littl
Autor:
Sen, Zheng, Huita, Wu, Fei, Wang, Jie, Lv, Jing, Lu, Qinliang, Fang, Fuqiang, Wang, Yuyan, Lu, Sheng, Zhang, Yaping, Xu, Qing, Bao, Chengrong, Xie, Zhenyu, Yin
Publikováno v:
Cancer Management and Research
Background: Due to the high recurrence and metastasis rate, the clinical outcomes of patients with hepatocellular carcinoma (HCC) are still unsatisfactory. Hepatitis B virus X-interacting protein (HBXIP) has been reported to play crucial roles in car